Related Experiment Videos
Hepatocyte giant mitochondria: an almost constant lesion in systemic scleroderma
Summary
Systemic scleroderma patients often show giant mitochondria in liver cells, regardless of disease stage or liver health. The cause of this cellular abnormality remains unknown in scleroderma research.
Area of Science:
- Hepatology
- Cell Biology
- Rheumatology
Background:
- Systemic scleroderma is an autoimmune disease affecting connective tissues.
- Liver involvement can occur in systemic scleroderma, but its cellular manifestations are not fully understood.
Purpose of the Study:
- To investigate the ultrastructural changes in hepatocytes of patients with systemic scleroderma.
- To identify specific cellular abnormalities associated with systemic scleroderma in the liver.
Main Methods:
- Liver tissue samples were obtained from 14 patients diagnosed with systemic scleroderma.
- Electron microscopy was utilized to examine the ultrastructure of hepatocytes.
Main Results:
- Giant mitochondria were observed in hepatocytes of 13 out of 14 patients (93%).
- This ultrastructural abnormality was consistently found across different types and durations of systemic scleroderma.
- Giant mitochondria were present even in cases where liver histology appeared normal.
Conclusions:
- Giant mitochondria represent a common ultrastructural finding in the liver of patients with systemic scleroderma.
- The presence of giant mitochondria is independent of disease characteristics and histological normality.
- The underlying mechanism driving giant mitochondria formation in systemic scleroderma requires further investigation.